Page last updated: 2024-08-26

equol and Coronary Disease

equol has been researched along with Coronary Disease in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Barinas-Mitchell, E; Birru, RL; Magnani, JW; Sekikawa, A; Veliky, CV; Zhang, X	1
Aizenstein, H; Chang, YF; Cui, C; Higashiyama, A; Ihara, M; Kakuta, C; Kuller, L; Lopez, O; Lopresti, B; Mathis, C; Miyamoto, Y; Sekikawa, A	1
Abourizk, RH; Bruno, RS; Fall, P; Hutchins-Wiese, HL; Kenny, AM; Kenyon-Pesce, L; Kerstetter, JE; Kleppinger, A; Lipcius, R; Mangano, KM; Prestwood, KM; Walsh, SJ	1
Adlercreutz, H; Barnard, G; Bugel, S; Cassidy, A; Dadd, T; Kohen, F; Marlin, S; Ogborne, RM; Piron, J; Powell, J; Talbot, DC	1

Reviews

2 review(s) available for equol and Coronary Disease

Article	Year
Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans. Nutrients, 2021, Oct-23, Volume: 13, Issue:11 Topics: Antioxidants; Cardiotonic Agents; Coronary Disease; Equol; Glycine max; Humans; Isoflavones; Signal Transduction	2021
Effect of S-equol and Soy Isoflavones on Heart and Brain. Current cardiology reviews, 2019, Volume: 15, Issue:2 Topics: Aged; Brain; Coronary Disease; Diet; Equol; Female; Glycine max; Heart; Humans; Isoflavones; Male; Middle Aged	2019

Trials

2 trial(s) available for equol and Coronary Disease

Article	Year
Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial. Nutrition research (New York, N.Y.), 2013, Volume: 33, Issue:12 Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dietary Supplements; Double-Blind Method; Equol; Female; Humans; Inflammation Mediators; Interleukin-6; Isoflavones; Patient Compliance; Postmenopause; Soybean Proteins	2013
Monoclonal antibody-based time-resolved fluorescence immunoassays for daidzein, genistein, and equol in blood and urine: application to the Isoheart intervention study. Clinical chemistry, 2007, Volume: 53, Issue:4 Topics: Animals; Antibodies, Monoclonal; Biological Availability; Coronary Disease; Dietary Supplements; Equol; Female; Fluoroimmunoassay; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Mice; Mice, Inbred BALB C; Postmenopause; Reproducibility of Results	2007

Article

Year

Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.

Nutrition research (New York, N.Y.), 2013, Volume: 33, Issue:12

Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dietary Supplements; Double-Blind Method; Equol; Female; Humans; Inflammation Mediators; Interleukin-6; Isoflavones; Patient Compliance; Postmenopause; Soybean Proteins

2013

Monoclonal antibody-based time-resolved fluorescence immunoassays for daidzein, genistein, and equol in blood and urine: application to the Isoheart intervention study.

Clinical chemistry, 2007, Volume: 53, Issue:4

Topics: Animals; Antibodies, Monoclonal; Biological Availability; Coronary Disease; Dietary Supplements; Equol; Female; Fluoroimmunoassay; Gas Chromatography-Mass Spectrometry; Genistein; Humans; Isoflavones; Mice; Mice, Inbred BALB C; Postmenopause; Reproducibility of Results

2007